The Munich Biotech Mafia expand to the US with a New TCR Startup
TCR2 Therapeutics was backed by the Munich biotech mafia, a group of wealthy veteran biotech…
Keep yourself up to date with the latest cell therapy news, including stem cell therapy, CAR-T cell therapy, and more. This section covers the latest updates on regulations, deals, and technology advancements of cell therapy companies.
TCR2 Therapeutics was backed by the Munich biotech mafia, a group of wealthy veteran biotech…
How do you solve a problem like lentiviral vector infections? CEVEC has done it. We…
How far away is biotech from a breakthrough with cell and gene therapy? While these…
The FDA puts one of Adaptimmune's TCR trials on a partial hold, pending more information…
Immunocore and Pierre Fabre have been representing Europe in this years' Society for Melanoma Research Congress.…
Adaptimmune and MSD are collaborating to test a therapy for multiple myeloma that combines some…
Based in Cologne, Germany, Cevec focuses on human cell-based expression system for production of biological therapies.…
Shares of Adaptimmune slid 12% yesterday morning after the company updated its TCR therapy to…
Medigene has licensed a few candidates from its TCR platform to one of the Boston…
Using the body's own tools to eradicate cancers has been a dream of Medicine for…
Belgium is a real pioneer in developing stem cell therapies. TiGenix pushes this precursor position…
TiGenix is licensing the rights for its cell therapy which is under EMA review and…